Rituximab induction only for sensitized kidney recipients?
In contrast to earlier studies that showed a beneficial influence of rituximab on HLA antibody production after kidney transplantation, a recent report by Ashimine et al. questions such an effect. That previous studies included presensitized patients who are more prone to antibody development, migh...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 October 2013
|
| In: |
Nature reviews. Nephrology
Year: 2013, Jahrgang: 9, Heft: 12, Pages: 703-705 |
| ISSN: | 1759-507X |
| DOI: | 10.1038/nrneph.2013.230 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nrneph.2013.230 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nrneph.2013.230 
|
| Verfasserangaben: | Christian Morath and Caner Süsal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1759914223 | ||
| 003 | DE-627 | ||
| 005 | 20220819222746.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210607s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nrneph.2013.230 |2 doi | |
| 035 | |a (DE-627)1759914223 | ||
| 035 | |a (DE-599)KXP1759914223 | ||
| 035 | |a (OCoLC)1341415284 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Morath, Christian |d 1973- |e VerfasserIn |0 (DE-588)124036155 |0 (DE-627)085595837 |0 (DE-576)293989923 |4 aut | |
| 245 | 1 | 0 | |a Rituximab induction only for sensitized kidney recipients? |c Christian Morath and Caner Süsal |
| 264 | 1 | |c 22 October 2013 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.06.2021 | ||
| 520 | |a In contrast to earlier studies that showed a beneficial influence of rituximab on HLA antibody production after kidney transplantation, a recent report by Ashimine et al. questions such an effect. That previous studies included presensitized patients who are more prone to antibody development, might explain this controversy. | ||
| 700 | 1 | |a Süsal, Caner |e VerfasserIn |0 (DE-588)102648037X |0 (DE-627)726772763 |0 (DE-576)37182673X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Nephrology |d Basingstoke : Nature Publishing Group, 2009 |g 9(2013), 12, Seite 703-705 |h Online-Ressource |w (DE-627)598094784 |w (DE-600)2490368-1 |w (DE-576)327495782 |x 1759-507X |7 nnas |a Rituximab induction only for sensitized kidney recipients? |
| 773 | 1 | 8 | |g volume:9 |g year:2013 |g number:12 |g pages:703-705 |g extent:3 |a Rituximab induction only for sensitized kidney recipients? |
| 856 | 4 | 0 | |u https://doi.org/10.1038/nrneph.2013.230 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/nrneph.2013.230 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210607 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 102648037X |a Süsal, Caner |m 102648037X:Süsal, Caner |d 910000 |d 911600 |d 50000 |e 910000PS102648037X |e 911600PS102648037X |e 50000PS102648037X |k 0/910000/ |k 1/910000/911600/ |k 0/50000/ |p 2 |y j | ||
| 998 | |g 124036155 |a Morath, Christian |m 124036155:Morath, Christian |d 50000 |e 50000PM124036155 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1759914223 |e 3935116535 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"3 S."}],"relHost":[{"title":[{"title_sort":"Nature reviews","title":"Nature reviews","partname":"Nephrology"}],"titleAlt":[{"title":"Nature reviews / Nephrology"},{"title":"Nephrology"}],"part":{"text":"9(2013), 12, Seite 703-705","volume":"9","extent":"3","year":"2013","pages":"703-705","issue":"12"},"pubHistory":["5.2009,4 -"],"language":["eng"],"recId":"598094784","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Rituximab induction only for sensitized kidney recipients?Nature reviews. Nephrology","note":["Gesehen am 09.03.2021"],"id":{"eki":["598094784"],"zdb":["2490368-1"],"issn":["1759-507X"]},"origin":[{"publisherPlace":"Basingstoke","publisher":"Nature Publishing Group","dateIssuedKey":"2009","dateIssuedDisp":"2009-"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"22 October 2013","dateIssuedKey":"2013"}],"id":{"doi":["10.1038/nrneph.2013.230"],"eki":["1759914223"]},"name":{"displayForm":["Christian Morath and Caner Süsal"]},"note":["Gesehen am 07.06.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1759914223","language":["eng"],"title":[{"title":"Rituximab induction only for sensitized kidney recipients?","title_sort":"Rituximab induction only for sensitized kidney recipients?"}],"person":[{"family":"Morath","given":"Christian","roleDisplay":"VerfasserIn","display":"Morath, Christian","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Süsal, Caner","given":"Caner","family":"Süsal"}]} | ||
| SRT | |a MORATHCHRIRITUXIMABI2220 | ||